MYC amplification is common in cancer of the stomach and gastroesophageal junction, correlates with male sex and reduced response to neoadjuvant therapy.

BMC Cancer · 2026 · PMC13107588 · PMID 42032556

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Due to the highly significant difference between men and women (52.1% vs. 29.2% MYC score 1) we analyzed men and women of the chemotherapy naive cohort separately.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.